| Date Filed | Type | Description |
| 02/21/2018 |
GN
| UPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized Cannabinoids, Opioids and Other Pharmaceutical Agents |
| 02/14/2013 |
SC 13G/A
| PUTNAM INVESTMENTS LLC reports a 1.3% stake in China Medical Tech-Spon ADR |
| 09/11/2012 |
SC 13G
| AER Advisors Inc reports a 37% stake in China Medical Technologies, Inc. |
| 08/29/2012 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
| 08/15/2012 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
| 08/07/2012 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
| 06/20/2012 |
SC 13D/A
| AER Advisors Inc reports a 9% stake in China Medical Technologies, Inc. |
| 06/12/2012 |
SC 13D
| AER Advisors Inc reports a 8.5% stake in China Medical Technologies, Inc. |
| 05/07/2012 |
SC 13G/A
| AER Advisors Inc reports a 21.2% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 04/05/2012 |
SC 13G/A
| AER Advisors Inc reports a 20% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 03/21/2012 |
SC 13G/A
| AER Advisors Inc reports a 18.7% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 02/22/2012 |
SC 13G/A
| AER Advisors Inc reports a 6% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 02/21/2012 |
SC 13G/A
| AER Advisors Inc reports a 15.2% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 02/21/2012 |
SC 13G/A
| AER Advisors Inc reports a 12% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 02/21/2012 |
SC 13G/A
| AER Advisors Inc reports a 6.3% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 02/21/2012 |
SC 13G
| AER Advisors Inc reports a 5.3% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2012 |
SC 13G/A
| PUTNAM INVESTMENTS LLC reports a 7.9% stake in China Medical Tech-Spon ADR |
| 02/14/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/03/2012 |
PRN
| Faruqi & Faruqi, LLP Files Securities Class Action Suit Against China Medical Technologies, Inc. and Certain of Its Executives |
| 12/14/2011 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
| 12/08/2011 |
SC 13G/A
| China Medical Technologies, Inc. reports a 0% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 11/30/2011 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 11/28/2011 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 11/21/2011 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
| 09/26/2011 |
4
| Tsang Takyung (CFO) has filed a Form 4 on China Medical Technologies, Inc.|
Txns:
| Bought 800 shares
@ $5, valued at
$4k
Bought 5,200 shares
@ $5, valued at
$26k
|
|
| 08/17/2011 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] |
| 08/16/2011 |
TRN
| China Medical Technologies Management Discusses F1Q 2011 Results |
| 08/10/2011 |
SC 13G/A
| China Medical Technologies, Inc. reports a 11.2% stake in CHINA MEDICAL TECHNOLOGIES, INC. |
| 07/18/2011 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
| 06/17/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2011 |
4
| Tsang Takyung (CFO) has filed a Form 4 on China Medical Technologies, Inc.|
Txns:
| Bought 5,000 shares
@ $7.34, valued at
$36.7k
|
|
| 06/10/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2011 |
4
| Tsang Takyung (CFO) has filed a Form 4 on China Medical Technologies, Inc.|
Txns:
| Bought 3,000 shares
@ $9.73, valued at
$29.2k
Bought 5,300 shares
@ $8.47, valued at
$44.9k
|
|
|